GERMS
Search This Blog
Tuesday, January 21, 2014
ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe | 2014 | Press releases | Media | GlaxoSmithKline
ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe | 2014 | Press releases | Media | GlaxoSmithKline
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.